BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 32170538)

  • 1. Purinergic signaling and tumor microenvironment in cervical Cancer.
    Pfaffenzeller MS; Franciosi MLM; Cardoso AM
    Purinergic Signal; 2020 Mar; 16(1):123-135. PubMed ID: 32170538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2Y
    Morrone FB; Vargas P; Rockenbach L; Scheffel TB
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purinergic Signaling Within the Tumor Microenvironment.
    Draganov D; Lee PP
    Adv Exp Med Biol; 2021; 1270():73-87. PubMed ID: 33123994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purinergic signaling in liver disease.
    Vaughn BP; Robson SC; Longhi MS
    Dig Dis; 2014; 32(5):516-24. PubMed ID: 25034284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purinergic Signaling in the Hallmarks of Cancer.
    Campos-Contreras ADR; Díaz-Muñoz M; Vázquez-Cuevas FG
    Cells; 2020 Jul; 9(7):. PubMed ID: 32635260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular ATP signaling and clinical relevance.
    Dou L; Chen YF; Cowan PJ; Chen XP
    Clin Immunol; 2018 Mar; 188():67-73. PubMed ID: 29274390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purinergic signaling as a new mechanism underlying physical exercise benefits: a narrative review.
    Cardoso AM; Silvério MNO; de Oliveira Maciel SFV
    Purinergic Signal; 2021 Dec; 17(4):649-679. PubMed ID: 34590239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular vesicles in cancer immune responses: roles of purinergic receptors.
    Graner MW
    Semin Immunopathol; 2018 Sep; 40(5):465-475. PubMed ID: 30209547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological roles of purinergic signaling in the liver.
    Vaughn BP; Robson SC; Burnstock G
    J Hepatol; 2012 Oct; 57(4):916-20. PubMed ID: 22709619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered purinergic signaling in the tumor associated immunologic microenvironment in metastasized non-small-cell lung cancer.
    Schmid S; Kübler M; Korcan Ayata C; Lazar Z; Haager B; Hoßfeld M; Meyer A; Cicko S; Elze M; Wiesemann S; Zissel G; Passlick B; Idzko M
    Lung Cancer; 2015 Dec; 90(3):516-21. PubMed ID: 26505137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine uptake is the major effector of extracellular ATP toxicity in human cervical cancer cells.
    Mello Pde A; Filippi-Chiela EC; Nascimento J; Beckenkamp A; Santana DB; Kipper F; Casali EA; Nejar Bruno A; Paccez JD; Zerbini LF; Wink MR; Lenz G; Buffon A
    Mol Biol Cell; 2014 Oct; 25(19):2905-18. PubMed ID: 25103241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophils: fast and furious-the nucleotide pathway.
    Rubenich DS; de Souza PO; Omizzollo N; Lenz GS; Sevigny J; Braganhol E
    Purinergic Signal; 2021 Sep; 17(3):371-383. PubMed ID: 33913070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular purines, purinergic receptors and tumor growth.
    Di Virgilio F; Adinolfi E
    Oncogene; 2017 Jan; 36(3):293-303. PubMed ID: 27321181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression Pattern of Purinergic Signaling Components in Colorectal Cancer Cells and Differential Cellular Outcomes Induced by Extracellular ATP and Adenosine.
    Dillard C; Borde C; Mohammad A; Puchois V; Jourdren L; Larsen AK; Sabbah M; Maréchal V; Escargueil AE; Pramil E
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory profile in cervical cancer: influence of purinergic signaling and possible therapeutic targets.
    Franciosi MLM; do Carmo TIT; Zanini D; Cardoso AM
    Inflamm Res; 2022 Jun; 71(5-6):555-564. PubMed ID: 35376994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of purinergic system in the release of cytokines by macrophages exposed to glioma-conditioned medium.
    Bergamin LS; Braganhol E; Figueiró F; Casali EA; Zanin RF; Sévigny J; Battastini AM
    J Cell Biochem; 2015 May; 116(5):721-9. PubMed ID: 25546398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine and paracrine purinergic signaling in the most lethal types of cancer.
    Reyna-Jeldes M; Díaz-Muñoz M; Madariaga JA; Coddou C; Vázquez-Cuevas FG
    Purinergic Signal; 2021 Sep; 17(3):345-370. PubMed ID: 33982134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purinergic Signaling During Immune Cell Trafficking.
    Ferrari D; McNamee EN; Idzko M; Gambari R; Eltzschig HK
    Trends Immunol; 2016 Jun; 37(6):399-411. PubMed ID: 27142306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purinergic signalling and cancer.
    Burnstock G; Di Virgilio F
    Purinergic Signal; 2013 Dec; 9(4):491-540. PubMed ID: 23797685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. History of ectonucleotidases and their role in purinergic signaling.
    Zimmermann H
    Biochem Pharmacol; 2021 May; 187():114322. PubMed ID: 33161020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.